Page 512 - Cardiac Nursing
P. 512

10.
                         10.
                       0-5
                    p46
                       0-5
                               0
                               0
                           qxd
                         10.
                           qxd
                                                    88
                                                         ara
                                                    88
                                                  e 4
                                                  e 4
                                                    88
                    p46
                                                       Apt
                                                         ara
                                                       Apt
                                9/0
                                               P
                                               P
                                             M
                                           8 A
                                             M
                                                 g
                                                 g
                                                a
                                               P
                                                a
                                    009
                                    009
                                  9/2
                                9/0
                                  9/2
                                        8:2
                                           8 A
                                        8:2
                                        0
                                        0
               0-c
            K34
               0-c
                 21_
                 21_
         L L LWB
         LWBK340-c21_21_p460-510.qxd  09/09/2009  08:28 AM  Page 488 Aptara
         LWB
            K34
            K34
                  488    P A R T  III / Assessment of Heart Disease
                  during induced hypothermia and rewarming postcardiac arrest.  The TPID methods are now used primarily to calibrate the pulse
                  The CCO is accurate at low flow rates (0.5 to 3 L/min), 318  and  contour. For thermodilution pulse contour analysis, calibration is
                  during tachycardia or atrial fibrillation. 319  However, at higher  based on the analysis of the area under the systolic portion of the
                  flow rates, there is an increased difference between the absolute  thermodilution curve and a coefficient characterizing vascular com-
                  CCO and TDCO, although the percent difference remains simi-  pliance. Once calibrated, the system (PiCCO) provides a beat-to-
                  lar. 312,320  The CCO on average overestimates the CO from a left  beat analysis of SV. The lithium-based system uses pulse power
                  ventricular assist device by approximately 0.5 L/min. 321  analysis, which uses a series of approximations regarding the rela-
                     A limitation of the CCO system is the delay between a change  tionship between radial artery pressure, aortic pressure, aortic flow,
                  in CO and display of the change. 322,323  The displayed CO is up-  and CO. 332  The LiDCO is then used to calibrate the system and
                  dated every 30 seconds and represents the average CO over the  convert the derived CO into a patient-specific CO. There have been
                  previous 3 to 6 minutes. Although newer technology has de-  concerns raised regarding the ability of these systems to accurately re-
                  creased the response time, when the two systems most commonly  flect the absolute or relative change in SV during periods of marked
                  used in practice were exposed to a 4-L/min CO change, they de-  hemodynamic instability, although the data remain equivocal. 333,334
                  tected 20% of the change in 5.3 to 6.5 minutes, 50% change in  The FloTrac/Vigileo System (Edwards Lifesciences, Irvine, Cal-
                  7.6 to 8.8 minutes, and 80% change in 10.8 to 11.1 minutes.  ifornia) also provides continuous SV monitoring. The system uses
                  When flow was changed by 1 L every 2 minutes, neither system  a proprietary sensor that can be attached to any arterial line. This
                  detected the change. 324  The observed changes in CO also lag be-  system does not require external calibration, rather the SV is de-
                  hind changes in MAP, HR, and   and TDCO. 315,325  The use  rived using the following equation (SV   K   pulsatility), where
                  of the STAT mode may be an option. In contrast to the concern  the calibration constant (K ) characterizes the patient’s vascular re-
                  that more frequent measurements may result in increased “noise,”  sistance and arterial compliance based on their sex, height, weight,
                  the bias ( 0.04 to 0.18 L/min) and precision (0.61 to 0.84  and age and the pulse pressure waveform characteristics, and pul-
                  L/min) of STAT mode versus TDCO were comparable to values  satility is derived from continuous analysis of the arterial pressure
                  comparing the TDCO with normal CCO. 326             waveform.  328,335  The early evaluation of this device found only
                     Several other factors may affect the accuracy and repeatability  moderate agreement with other CO methods; 316,336–343  however,
                  of CCO measurements. The infusion of a cold solution may cause  derived CO measurements using a new algorithm (version 1.10),
                  overestimation of CCO measurements, although CCO measure-  which updates the calibration every minute, is generally compara-
                  ments are minimally affected by fluctuations in PA tempera-  ble to other CO measurement devices. 344,345  However, in hemo-
                  tures. 304,327  In addition, fluid boluses cause an underestimation of  dynamically unstable patients there was an unacceptable difference
                  CO in low flow states (CO   4 L/min). Intracardiac shunt, tri-  (56%) in FloTrac CO compared with thermodilution CO. 346,347
                  cuspid regurgitation, and incorrect catheter placement (thermal  A concern regarding these noninvasive indices is that changes in
                  filament in the vena cava or in contact with the heart) decrease the  vascular resistance may necessitate recalibration of the system. The
                  accuracy of CCO measures.                           manufacturers recommend recalibration of the LiDCO and
                                                                      PiCCO systems every 8 hours or with marked changes in hemo-
                                                                      dynamic status. 348,349  Unfortunately, there is no standard defini-
                     LESS INVASIVE METHODS FOR                        tion of what a “marked change” in hemodynamics is. One study
                     CO MONITORING                                    found that while small changes in SVR ( 20%) do not affect the
                                                                      pulse contour measurements, a greater than 50% increase in SVR
                  Over the past decade, there has been increased emphasis on de-  increases the bias between PiCCO and TDCO measurements. 350
                  veloping less invasive methods for CO monitoring. Intermittent  In a recent study using the PiCCO system, while the TPTD and
                                                                                                            2
                  CO measurements using the TPID technique involve injection of  the derived CO correlated over an 8-hour period (r   0.68) the
                                                                                                           r
                                                                                                           r
                  an indicator into the venous circulation with a sensor in the sys-  difference between the value was less than 30% for only the first
                  temic arterial circulation. There are currently two TPID CO tech-  hour after calibration and when the SVR changed more than 15%
                  niques that have been validated against other CO measurement  the error was 36%. 351  In another study, the LiDCO CO was
                  methods. 328  The Transpulmonary Thermodilution (TPID)  within acceptable levels of agreement for only 4 hours after recali-
                  method uses a 10 to 15 mL injection of iced D5W or saline via a  bration 352  and in an animal model of acute hemorrhage the
                  central catheter (subclavian or jugular) as the indicator with a 4-Fr  LiDCO overestimated CO, suggesting the need to recalibrate with
                  thermistor-tipped arterial catheter placed in the femoral, brachial,  acute changes in preload, afterload, or contractility. 353  An algo-
                  or axillary artery (PiCCO; Pulsion Medical Systems, Munich, Ger-  rithm for the PiCCO system that accounts for vascular compliance
                  many). Recently, a study suggests that the thermistor-tipped  and resistance was studied in postoperative cardiac surgery patients
                  catheter may also be placed in the radial artery. 329  Injection of the  with CO changes greater than 20% (	CO 40%   27%) and a
                                                                                                       –5
                  cold solution through the femoral vein also produces reliable esti-  wide range of SVRs (450 to 2,360 dynes/s/cm ). The PiCCO CO
                  mates, but absolute CO values are higher than those obtained using  was closely correlated (r   0.88) and similar to TDCO measures
                  the jugular vein due to increased transit time. The LiDCO system  (bias    0.2  1.2 L/min), although there was increased variabil-
                  (LiDCO; London, UK) uses a subtherapeutic bolus of lithium in-  ity in the CO in contrast to hemodynamically stable patients. 349
                  jected via a peripheral or central catheter as the indicator. The  These data suggest that the systems need to be recalibrated when
                  lithium bolus is detected and a time curve, which is used to derive  there is a greater than 15% to 20% change in SVR or CO.
                  the CO, is created by a lithium-sensitive electrode attached to an ar-  Another concern about using these less invasive methods is the
                  terial pressure monitoring line. 330  The dose of lithium is too small  lack of information about the risk  for pulmonary edema.
                  to create a pharmacological effect; 331  however, LiDCO measure-  Transpulmonary indicator thermodilution methods allow for the
                  ments cannot be performed in patients receiving lithium and neu-  measurement of both intrathoracic blood volume and extravascu-
                  romuscular blocking agents may also interfere with calibration.  lar lung water (EVLW). 225  The EVLW is normally between 3 and
   507   508   509   510   511   512   513   514   515   516   517